KBI Biopharma | Contract Development and Manufacturing …
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.
Commercial Manufacturing - KBI Biopharma
KBI Biopharma offers a broad range of cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Our capabilities include reliable manufacturing for commercial supply. KBI’s experienced team produces high-quality therapeutics and vaccines through processes developed in-house or through processes transferred in from our ...
KBI Biopharma Expands US Operations With New $150 Million Commercial …
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, announced today the establishment of a new commercial manufacturing facility in Research Triangle Park (RTP) in North Carolina. KBI expects the $150 million, 140,000-square-foot facility to be operational by Q1 2022.
KBI Biopharma Expands US Operations with New $150 Million Commercial …
2020年12月1日 — DURHAM, N.C.-- ( BUSINESS WIRE )--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, announced today the establishment of a new commercial manufacturing facility in Research Triangle...
KBI Biopharma Holds Ribbon Cutting for New Commercial …
DURHAM (April 21, 2022)—KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, held a ribbon-cutting at the company’s new state-of-the-art $150 million, 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina. The location provides access to highly specialized talent and second-to-none ...
Following a Successful FDA Inspection, KBI Biopharma Extends …
2024年7月23日 — Global partners are utilizing KBI’s technologies to advance more than 170 drug candidates in preclinical and clinical development and the manufacture of ten commercial products.
KBI Biopharma Holds Ribbon Cutting for New Commercial …
2022年4月21日 — DURHAM, N.C.-- ( BUSINESS WIRE )--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, held a ribbon-cutting at the company’s new state-of-the-art $150 million, 150,000 square-foot...
KBI Biopharma Expands US Operations with New $150 Million Commercial …
DURHAM, NC – December 1, 2020 – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, announced today the establishment of a new commercial manufacturing facility in Research Triangle Park (RTP) in North Carolina. KBI expects the $150 million, 140,000-square-foot facility to be operational by Q1 2022.
Following a Successful FDA Inspection, KBI Biopharma Extends …
2024年7月23日 — Global partners are utilizing KBI’s technologies to advance more than 160 drug candidates in preclinical and clinical development and the manufacture of ten commercial products.
Following a Successful FDA Inspection, KBI Biopharma Extends …
2024年7月23日 — DURHAM, N.C. — KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced that it has extended and expanded its manufacturing contract with a leading global pharmaceutical company.